|
 |
|
The 2011 Coagulation Testing Market: US, Europe, Japan - Emerging Business Opportunities and Market Expansion Strategies for Suppliers
This comprehensive seven-country report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the coagulation market during the next decade. The report explores business and technological trends in the US, five major European countries (France, Germany, Italy, Spain, UK) and Japan; provides estimates of the test volume, instrument placements and installed base, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next ten years....
|
 |
|
$28700.00 |
| |
|
|
|
Transfusion Diagnostic Testing Market: US, Europe, Japan--Emerging Opportunities And Business Expansion Strategies for Suppliers
Rationale During the next ten years, the transfusion diagnostics market will undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology.
|
|
|
$28600.00 |
| |
|
|
|
The Blood Banking Market: US, Europe, Japan - Emerging Opportunities and Business Development Strategies
During the next ten years, the blood banking market will undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations advances in diagnostic technologies, IT, system engineering and automation and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation is more critical than underlying technology....
|
|
|
$28500.00 |
| |
|
|
|
The 2011 Cancer Diagnostics Market: US, Europe, Japan - Emerging Opportunities and Business Expansion Strategies for Suppliers
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field....
|
|
|
$28500.00 |
| |
|
|
|
Global NAT Market
This comprehensive seven-country, 1,050-page report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the NAT market during this decade.Highlights - Business and technological trends in seven major markets
- Five- and ten-year test volume and sales forecasts
- Market shares of leading competitors
- Feature comparison of major analyzers
- Profiles of market players and start-up firms developing innovative technologies
and products
- Specific product and business opportunities for instrument and consumable suppliers.
|
|
|
$28500.00 |
| |
|
|
|
Hepatitis B Drug Market Forecasts by Country
This model contains ten-year commercial forecasts for hepatitis B drug sales by class, molecule and brand for the US, Japan, France, Germany, Italy, Spain, UK and Turkey. Reasons to Purchase - Understand the changing market dynamics of hepatitis B drugs, and success factors for leading brands....
|
|
|
$15200.00 |
| |
|
|
|
HIV Antiretrovirals Market Forecasts
In 2009, HIV antiretrovirals sales across the seven major markets totalled $11.8 billion, growing at a CAGR of 10....
|
|
|
$15200.00 |
| |
|
|
|
Antihormonal Therapy Market Forecasts
Antihormonal cancer therapies are used predominantly in the treatment of breast and prostate cancers. The high incidence of these tumors translates into a significant commercial potential for drug developers....
|
|
|
$15200.00 |
| |
|
|
|
Cytotoxic Therapies: Drug Launches in Rare Indications to Offset Sales Decline
Growth of cytotoxics will remain static over the forecast period with a CAGR of -0.1%....
|
|
|
$15200.00 |
| |
|
|
|
Antihormonal Cancer Therapies: Leading Brands Strive to Minimize Generic Sales Erosion
Antihormonal cancer therapies are used predominantly in the treatment of breast and prostate cancers. The high incidence of these tumors translates into a significant commercial potential for drug developers....
|
|
|
$15200.00 |
| |
|
|
|
Gastric Cancer
Despite advances in surgery and the use of multimodality therapy, survival outcomes remain poor for gastric cancer patients. There is an urgent need for more effective therapies to improve survival rates in patients presenting with both localized and advanced disease....
|
|
|
$15200.00 |
| |
|
|
|
Spondyloarthropathies: Disease Perception Limits Market
Psoriatic arthritis and ankylosing spondylitis form part of the group of diseases known as the spondyloarthropathies. Psoriatic arthritis is a form of inflammatory arthritis associated with psoriasis, whilst ankylosing spondylitis causes arthritis of the spine and sacroiliac joints....
|
|
|
$15200.00 |
| |
|
|
|
The 2011 Top Ten World's Leading Pharmaceutical Companies
A thought-provoking report on performance, capabilities, goals and strategies of the major competitors in the worldwide pharmaceutical market. The report is designed to provide the pharmaceutical industry executives with strategically significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs....
|
|
|
$13200.00 |
| |
|
|
|
Three Alternative Scenarios of the Future In Vitro Diagnostics Market through 2018
This report is an invaluable strategic planning resource for corporate, marketing and R&D executives. The report is designed to help executives develop effective contingency plans that best accommodate uncertainties ahead....
|
|
|
$11800.00 |
| |
|
|
|
The Top 10 World's Leading Biotechnology Companies
The report contains over 700 pages, 70 tables,
and presents the following information:
I. Worldwide Market Overview
- US and international trends
- Analysis of major market segments
- Review of main geographic regions
- Worldwide market forecasts
II....
|
|
|
$11800.00 |
| |
|
|
|
US Blood Banking Market
This report presents a comprehensive analysis of the US blood banking market, including:- Major issues pertaining to the US blood banking practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Specifically, the study explores the impact of anticipated changes in government regulations, trends in complicated surgeries, birth rate and other key issues....
|
|
|
$8900.00 |
| |
|
|
|
The 2011 US Coagulation Market
This report presents a comprehensive analysis of the US coagulation market, including:- Major issues pertaining to the US coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Ten-year volume and sales forecasts for 40 coagulation procedures performed in US hospitals, commercial laboratories, and physician offices, including typical coagulation daily work loads....
|
|
|
$8500.00 |
| |
|
|
|
Pharmaceutical M&A in Asia-Pacific: India and China Drive Regional Activity, but Japan Dominates High Value Transactions
Expanding healthcare coverage in emerging Asia-Pacific markets, rapid economic growth and burgeoning middle classes are attracting foreign M&A as companies attempt to offset future losses from the looming threat of the 2011 "patent cliff" and slowing growth in major developed markets. As these markets expand, consolidation of the domestic industry is also driving M&A in the Asia-Pacific region....
|
|
|
$7600.00 |
| |
|
|
|
|